Industry Standard Research’s (ISR) “2013 CRO Quality Benchmarking – Phase IV Service Providers” report provides pharmaceutical sponsors and clinical service providers an independent and comprehensive analysis of CRO service quality to assist with the outsourcing of Phase IV clinical trial activities.
This year, ISR’s Phase IV report includes data from 208 unique service evaluations across 27 Phase IV service providers.